Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease

被引:37
|
作者
Vynnycky, E. [1 ]
Borgdorff, M. W. [2 ,3 ]
Leung, C. C. [4 ]
Tam, C. M. [4 ]
Fine, P. E. M. [5 ]
机构
[1] Hlth Protect Agcy, Modelling & Econ Unit, Ctr Infect, London NW9 5HT, England
[2] KNCV TB Fdn, The Hague, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[4] Wanchai Chest Clin, Hong Kong, Hong Kong, Peoples R China
[5] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, Dept Epidemiol & Populat Hlth, London WC1, England
来源
EPIDEMIOLOGY AND INFECTION | 2008年 / 136卷 / 07期
基金
英国医学研究理事会;
关键词
D O I
10.1017/S0950268807008552
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Over 50% of the global burden of tuberculosis occurs in South East Asia and the Western Pacific. Since 1950, notification rates in high-income countries in these settings have declined slowly and have remained over ten-fold greater than those in Western populations. The reasons for the slow decline are poorly understood. Using an age-structured model describing the incidence of Mycobacterium tuberculosis infection and disease applied to notification data from Hong Kong, we illustrate that in Hong Kong, a high prevalence of M. tuberculosis infection among older individuals and a high risk of disease through reactivation (e.g. up to 17-fold greater than that estimated for infected males in the United Kingdom) may explain this slow decline. If this feature of the epidemiology of tuberculosis is widespread, the WHO directly observed treatment short-course (DOTS) strategy may have a smaller impact in Asia in the short term than has been-implied by recent predictions, all of which have been based on disease risk estimates derived from Western Europe. As a result, it may be difficult to meet the targets for tuberculosis control, which have been prescribed by the UN Millennium Development Goals.
引用
收藏
页码:943 / 952
页数:10
相关论文
共 50 条
  • [11] PSYCHOSOCIAL IMPACT OF HUNTINGTONS-DISEASE ON HONG-KONG CHINESE FAMILIES
    WONG, MTH
    CHANG, PCM
    YU, YL
    CHAN, YW
    CHAN, V
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 90 (01) : 16 - 18
  • [12] Guest Editorial: Health protection and communicable disease control in Hong Kong, China
    Tse, L. A.
    Griffiths, S. M.
    PUBLIC HEALTH, 2012, 126 (12) : 999 - 1000
  • [13] The Hong Kong infection control nurses’ association (HKICNA) – small establishment big impact
    CHS Lam
    PTY Ching
    WH Seto
    W Jarvis
    D Pittet
    BMC Proceedings, 5 (Suppl 6)
  • [14] Assessing economic impact of sovereignty transfer over Hong Kong: a synthetic control approach
    Li, Jing
    Sangal, Sarina
    Shao, Ling
    APPLIED ECONOMICS, 2021, 53 (30) : 3499 - 3514
  • [15] The impact of oral disease among the institutionalized and non-institutionalized elderly in Hong Kong
    McMillan, AS
    Wong, MCM
    Lo, ECM
    Allen, PF
    JOURNAL OF ORAL REHABILITATION, 2003, 30 (01) : 46 - 54
  • [16] SYMPTOMS OF NEWLY DIAGNOSED PULMONARY TUBERCULOSIS AND PATIENTS ATTITUDES TO THE DISEASE AND TO ITS TREATMENT IN HONG-KONG
    ALLAN, WGL
    GIRLING, DJ
    FAYERS, PM
    FOX, W
    TUBERCLE, 1979, 60 (04): : 211 - 223
  • [17] Tuberculous pleurisy as a manifestation of primary and reactivation disease in a region with a high prevalence of tuberculosis
    Liam, CK
    Lim, KH
    Wong, CMM
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (09) : 816 - 822
  • [18] Littorinids control high intertidal biofilm abundance on tropical, Hong Kong rocky shores
    Mak, YM
    Williams, GA
    JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY, 1999, 233 (01) : 81 - 94
  • [19] High seroprevalence of Borna Disease Virus infection in Chinese schizophrenic patients in Hong Kong
    Chen, RY
    Cheung, EF
    Galabru, J
    Chen, EY
    Lin, CK
    Saron, M
    SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 28 - 28
  • [20] Bayesian disease mapping and the 'High-Risk' oral cancer population in Hong Kong
    Adeoye, John
    Choi, Siu-Wai
    Thomson, Peter
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2020, 49 (09) : 907 - 913